Literature DB >> 7923881

Serological association of lupus autoantibodies to a limited functional domain of 28S ribosomal RNA and to the ribosomal proteins bound to the domain.

T Sato1, T Uchiumi, M Arakawa, R Kominami.   

Abstract

Site-specific anti-RNA antibodies were sought in 120 sera of patients with autoimmune diseases by ribonuclease-protection assay using six fragments covering 28S ribosomal RNA (rRNA) as antigens. Fifteen of 90 sera from patients with systemic lupus erythematosus (SLE), but none of 30 sera of the other autoimmune diseases, provided a 60 nucleotide fragment within a region termed the 'GTPase domain' of 28S rRNA. These sera had potency to precipitate 0.42-69.3 nmol of the RNA domain per ml serum, which was higher than 15 control sera of healthy donors. No other specific antigenic site was detected in 28S rRNA under conditions used. All of the 15 sera having this anti-RNA antibody showed reactivity to ribosomal P proteins (anti-P), and two of them contained an additional antibody to ribosomal protein L12. These results suggested a strong association of the production of these three antibodies. Since P and L12 proteins form a stable complex with the GTPase domain, this serological association may result from an immune response to epitopes clustered on a single RNA-protein complex domain in ribosomes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923881      PMCID: PMC1534158          DOI: 10.1111/j.1365-2249.1994.tb06603.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Direct evidence for interaction of the conserved GTPase domain within 28 S RNA with mammalian ribosomal acidic phosphoproteins and L12.

Authors:  T Uchiumi; R Kominami
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

Review 2.  Ribosomal RNA and translation.

Authors:  H F Noller
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

3.  The activity of the acidic phosphoproteins from the 80 S rat liver ribosome.

Authors:  W P MacConnell; N O Kaplan
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

4.  Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease.

Authors:  T Sato; T Uchiumi; T Ozawa; M Kikuchi; M Nakano; R Kominami; M Arakawa
Journal:  J Rheumatol       Date:  1991-11       Impact factor: 4.666

5.  Epitope regions on U1 small nuclear RNA recognized by anti-U1RNA-specific autoantibodies.

Authors:  R M Hoet; P De Weerd; J K Gunnewiek; I Koornneef; W J Van Venrooij
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

6.  A ribonucleic acid-specific antibody produced during autoimmune disease: evidence for nucleotide sequence specificity.

Authors:  D Eilat; S A Ben Sasson; R Laskov
Journal:  Eur J Immunol       Date:  1980-11       Impact factor: 5.532

7.  A human autoantibody specific for a unique conserved region of 28 S ribosomal RNA inhibits the interaction of elongation factors 1 alpha and 2 with ribosomes.

Authors:  T Uchiumi; R R Traut; K Elkon; R Kominami
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

8.  Antibodies to ribosomal ribonucleic acid (rRNA) in patients with systemic lupus erythematosus (SLE).

Authors:  E W Lamon; J C Bennett
Journal:  Immunology       Date:  1970-09       Impact factor: 7.397

9.  Lupus antiribosomal P antisera contain antibodies to a small fragment of 28S rRNA located in the proposed ribosomal GTPase center.

Authors:  J L Chu; N Brot; H Weissbach; K Elkon
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

10.  A functional site of the GTPase-associated center within 28S ribosomal RNA probed with an anti-RNA autoantibody.

Authors:  T Uchiumi; R Kominami
Journal:  EMBO J       Date:  1994-07-15       Impact factor: 11.598

View more
  9 in total

1.  The Interaction between the Ribosomal Stalk Proteins and Translation Initiation Factor 5B Promotes Translation Initiation.

Authors:  Ryo Murakami; Chingakham Ranjit Singh; Jacob Morris; Leiming Tang; Ian Harmon; Azuma Takasu; Tomohiro Miyoshi; Kosuke Ito; Katsura Asano; Toshio Uchiumi
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

2.  Characterization of anti-P monoclonal antibodies directed against the ribosomal protein-RNA complex antigen and produced using Murphy Roths large autoimmune-prone mice.

Authors:  H Sato; M Onozuka; A Hagiya; S Hoshino; I Narita; T Uchiumi
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

3.  Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus.

Authors:  J L J Lin; V Dubljevic; M J Fritzler; Ban-Hock Toh
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

4.  Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies.

Authors:  A Ghirardello; A Doria; S Zampieri; R Gerli; E Rapizzi; P F Gambari
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

5.  The Blood of the HIV-Infected Patients Contains κ-IgG, λ-IgG, and Bispecific κλ-IgG, Which Possess DNase and Amylolytic Activity.

Authors:  Anna Timofeeva; Sergey Sedykh; Lada Maksimenko; Tatyana Sedykh; Sergey Skudarnov; Tatyana Ostapova; Svetlana Yaschenko; Natalya Gashnikova; Georgy Nevinsky
Journal:  Life (Basel)       Date:  2022-02-17

6.  Anti-transfer RNA antibodies in two patients with pulmonary fibrosis, Raynaud's phenomenon and polyarthritis.

Authors:  Y Ohosone; M Matsumura; J Chiba; S Nagaoka; Y Matsuoka; S Irimajiri; T Mimori
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 7.  Catalytic Antibodies: Design, Expression, and Their Applications in Medicine.

Authors:  Daqun Zhao; Jie Chen; Xiaoyue Hu; Shujun Zhang
Journal:  Appl Biochem Biotechnol       Date:  2022-10-12       Impact factor: 3.094

Review 8.  Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?

Authors:  Emese Kiss; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

9.  DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia.

Authors:  Evgeny A Ermakov; Ludmila P Smirnova; Taisiya A Parkhomenko; Pavel S Dmitrenok; Nina M Krotenko; Nikolai S Fattakhov; Nikolay A Bokhan; Arkadiy V Semke; Svetlana A Ivanova; Valentina N Buneva; Georgy A Nevinsky
Journal:  Open Biol       Date:  2015-09       Impact factor: 6.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.